It was a tremendous pleasure serving as FITsOnTheGo Co-Director at #ACC25 alongside these wonderful humans and colleagues. Grateful for the chance to meet and connect with trialists and trainees from around the world. Thanks Mayo Clinic Rochester Cardiology Fellows for this great opportunity.

Our own Mohamad Alkhouli presenting at TCT Middle East in Riyadh, Saudi Arabia on the early experience with Adona device. Mayo Clinic CV Mayo Clinic Rochester Cardiology Fellows TCTME+

Shark Tank Innovation Competition at TCT Middle East. Mohamad Alkhouli is presenting the Cryo X thrombus removal platform. Mayo Clinic CV Mayo Clinic Rochester Cardiology Fellows TCTME+

Excellent evening program at TCT Middle East: Women’s Cardiovascular Research Consortium. TCTME+

We presented our results at TCT Middle East in Riyadh, Saudi Arabia TCTME+ Thanks to the project leads for the support Abdullah Al-Abcha Mohamad Alkhouli Mayo Clinic Rochester Cardiology Fellows Mayo Clinic CV

Selfies ..impressive 450 faculty attending the inaugural TCTME+ meeting Riyadh from all 5 continents 🫶😁 Bailey Ann Estes 🇺🇸 Ahmed Suliman, MBBS, FACP, FESC, FACC 🇸🇩 Altayyeb Yousef 🇰🇼 Dr Mohammed Sobhy 🇪🇬 Stage managers & Cardiovascular Research Foundation directors Karim Al-Azizi, MD Marwan Saad, MD, PhD David J. Cohen, MD, MSc Juan F. Granada

Cardiogenic shock in Takotsubo can result from myocardial stunning or dynamic LVOT obstruction. Be cautious with inotropes—they can worsen obstruction and hypotension. Volume (if tolerated) may help. #FellowTips #CardioX Benjamin Hibbert

LBBB EKG criteria include the absence of Q waves in leads I, V5, and V6. This helps distinguish true LBBB from a nonspecific intraventricular conduction delay. The loss of septal Q waves occurs because normal left-to-right septal depolarization is disrupted by the conduction

Hany Ragy Salman Arain Ziad Ali Mamas A. Mamas Carlos Collet MD PhD Gregg W. Stone MD The best way to reduce atherosclerotic risk related to high TG is to get apoB to control (<70 mg/dL). Once that is done if TG are still high (> 500 mg/dL - pancreatitis risk) add high dose (4 gm) of omega 3 product or use fenofibrate if renal function is OK and patient not on

A striking example of double-site obstruction in hypertrophic cardiomyopathy. The apical view demonstrates color Doppler flow acceleration in the LVOT with systolic anterior motion of the mitral valve during Valsalva. The CW Doppler reveals two distinct peaks — the first

The movers & the shakers.. #TCTPlusMiddleEast team at the Moscone center preparing for the second iteration of the conference #InnovateDontReplicate Stay tuned for updates due for release this November Cardiovascular Research Foundation TCT Conference Juan F. Granada David J. Cohen, MD, MSc Khaled AlShaibi DR. Hani Najm

Once the forgotten, tricuspid valve is now the center of attention. TR is the most prevalent valvular heart disease among U.S. adults aged 65 to 85 years. #TCT2025 #PREVUEVALVE

Grateful for an incredible experience at #TCT2025 — from presenting our latest research to connecting with mentors and catching up with friends. Huge thanks to TCTMD Cardiovascular Research Foundation Mayo Clinic CV Mayo Clinic Rochester Cardiology Fellows

Contratulations Mohanad Hamandi, MD for this important contribution! MAC with mitral valve dysfunction and tricuspid regurgitation often coexist. It's important to study this as we enter the commercial era for TMVR in MAC with already 1 TMVR device (Tendyne) FDA approved for patients with